| Gene symbol | ERBB2 | Synonyms | CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19, NEU, NGL, TKR1, VSCN2, c-ERB-2, c-ERB2, p185(erbB2) | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q12 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | erb-b2 receptor tyrosine kinase 2 | ||||
| GTO ID | GTC1550 |
| Trial ID | NCT02547961 |
| Disease | Breast Cancer |
| Altered gene | HER2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | HER2 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | Chimeric Antigen Receptor-Modified T Cells for Breast Cancer |
| Year | 2015 |
| Country | China |
| Company sponsor | Fuda Cancer Hospital, Guangzhou |
| Other ID(s) | Breast Cancer CAR-T 001 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||
|
|||||||||